股票 › ABBV
艾伯维 ABBV
美股市值排名 #28
$291.31 +$3.07 (+1.07%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $291.31 0.00%
开盘$282.27
昨收$288.24
当日区间$281.07 – $291.73
成交量5.04M
市值$514.92B
市盈率（TTM）50.1
股息率2.34%
ABBV 相关新闻
匹配 AbbVie 或代码 ABBV 的头条新闻，按最新排序。
- News On Apogee Therapeutics Inc. (APGE) Now Under ABBV
- BMO Capital Maintains AbbVie(ABBV.US) With Buy Rating, Maintains Target Price $300
- Scotiabank Maintains AbbVie(ABBV.US) With Buy Rating, Maintains Target Price $280
- RBC Capital Maintains AbbVie(ABBV.US) With Buy Rating, Maintains Target Price $280
- Scotiabank Maintains AbbVie(ABBV.US) With Buy Rating, Maintains Target Price $280
- RBC Capital Maintains AbbVie(ABBV.US) With Buy Rating, Maintains Target Price $280
- Erste Group Upgrades AbbVie(ABBV.US) to Buy Rating 正面
- Guggenheim Maintains AbbVie(ABBV.US) With Buy Rating, Raises Target Price to $288 正面
- AbbVie 2Q U.S. HUMIRA Rev $425M ABBV
- BofA Securities Maintains AbbVie(ABBV.US) With Buy Rating, Raises Target Price to $282 正面
- BofA Securities Upgrades AbbVie(ABBV.US) to Buy Rating, Raises Target Price to $282 正面
- TD Cowen Initiates AbbVie(ABBV.US) With Buy Rating, Announces Target Price $280
- BMO Capital Maintains AbbVie(ABBV.US) With Buy Rating, Maintains Target Price $300
- A Quick Look at Today's Ratings for AbbVie(ABBV.US), With a Forecast Between $280 to $300
- TD Cowen Maintains AbbVie(ABBV.US) With Buy Rating, Maintains Target Price $280
暂无评论——快来第一个聊聊 ABBV。